Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
GSK withdraws its application for Abacavir in India
GSK drops claims on two Aids medicines
What’s happening: An update on HIV drugs in India
Time to re-write or clarify the pre-grant opposition rules?
Pre-95 drugs are not patentable in India – or are they?
News on I-MAK Study on 2nd Line HIV drugs
What’s Happening: An Update on HIV Drug Patents
En Garde!
Bridges on the Dismissal of the Novartis Patent Challenge
The Economic Times -Efficacy